Acadian Asset Management LLC Corcept Therapeutics Inc Transaction History

Acadian Asset Management LLC

  • $34.5 Billion
  • Q4 2024

A detailed history of Acadian Asset Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 114,490 shares of CORT stock, worth $7.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
114,490
Previous 24,906 359.69%
Holding current value
$7.27 Million
Previous $1.15 Million 400.87%
% of portfolio
0.02%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$44.66 - $60.85 $4 Million - $5.45 Million
89,584 Added 359.69%
114,490 $5.77 Million
Q3 2024

Nov 12, 2024
SELL
$29.51 - $46.26 $94,048 - $147,430
-3,187 Reduced 11.34%
24,906 $1.15 Million
Q2 2024

Aug 06, 2024
SELL
$22.21 - $34.48 $4.62 Million - $7.18 Million
-208,106 Reduced 88.11%
28,093 $912,000
Q1 2024

May 10, 2024
SELL
$21.1 - $27.46 $793,338 - $1.03 Million
-37,599 Reduced 13.73%
236,199 $5.94 Million
Q4 2023

Feb 13, 2024
SELL
$24.82 - $32.88 $1.1 Million - $1.45 Million
-44,229 Reduced 13.91%
273,798 $8.89 Million
Q3 2023

Nov 13, 2023
BUY
$21.97 - $33.8 $6.35 Million - $9.77 Million
289,023 Added 996.49%
318,027 $8.65 Million
Q2 2023

Aug 07, 2023
BUY
$21.44 - $25.15 $419,623 - $492,235
19,572 Added 207.51%
29,004 $645,000
Q4 2022

Feb 14, 2023
SELL
$19.95 - $29.96 $426,550 - $640,574
-21,381 Reduced 69.39%
9,432 $191,000
Q2 2022

Aug 09, 2022
SELL
$17.33 - $25.3 $17,884 - $26,109
-1,032 Reduced 3.24%
30,813 $733,000
Q1 2022

May 12, 2022
BUY
$16.53 - $25.21 $17,058 - $26,016
1,032 Added 3.35%
31,845 $716,000
Q4 2021

Feb 10, 2022
BUY
$17.1 - $23.34 $65,817 - $89,835
3,849 Added 14.27%
30,813 $610,000
Q3 2021

Nov 12, 2021
BUY
$19.68 - $22.53 $51,719 - $59,208
2,628 Added 10.8%
26,964 $530,000
Q2 2021

Aug 11, 2021
BUY
$19.97 - $24.43 $104,503 - $127,842
5,233 Added 27.39%
24,336 $535,000
Q1 2021

May 11, 2021
SELL
$23.49 - $30.56 $2.24 Million - $2.91 Million
-95,281 Reduced 83.3%
19,103 $454,000
Q4 2020

Feb 11, 2021
SELL
$16.78 - $27.3 $564,848 - $918,972
-33,662 Reduced 22.74%
114,384 $2.99 Million
Q3 2020

Nov 09, 2020
SELL
$12.46 - $19.98 $2.17 Million - $3.49 Million
-174,478 Reduced 54.1%
148,046 $2.58 Million
Q2 2020

Aug 12, 2020
SELL
$11.0 - $18.26 $316,228 - $524,938
-28,748 Reduced 8.18%
322,524 $5.42 Million
Q1 2020

May 11, 2020
BUY
$10.11 - $14.04 $1.79 Million - $2.49 Million
177,238 Added 101.84%
351,272 $4.18 Million
Q4 2019

Feb 06, 2020
SELL
$12.06 - $16.96 $410,100 - $576,724
-34,005 Reduced 16.35%
174,034 $2.11 Million
Q3 2019

Nov 07, 2019
SELL
$10.41 - $14.66 $734,540 - $1.03 Million
-70,561 Reduced 25.33%
208,039 $2.94 Million
Q2 2019

Aug 08, 2019
SELL
$9.78 - $12.76 $1.3 Million - $1.7 Million
-133,243 Reduced 32.35%
278,600 $3.11 Million
Q1 2019

May 09, 2019
BUY
$10.03 - $15.71 $2.06 Million - $3.23 Million
205,567 Added 99.66%
411,843 $4.84 Million
Q4 2018

Feb 07, 2019
SELL
$11.29 - $17.19 $13.8 Million - $21 Million
-1,220,223 Reduced 85.54%
206,276 $2.76 Million
Q3 2018

Oct 30, 2018
SELL
$12.27 - $15.65 $16.7 Million - $21.3 Million
-1,359,742 Reduced 48.8%
1,426,499 $20 Million
Q2 2018

Jul 24, 2018
SELL
$15.3 - $19.69 $8.08 Million - $10.4 Million
-528,328 Reduced 15.94%
2,786,241 $43.8 Million
Q1 2018

Apr 12, 2018
BUY
$14.59 - $25.5 $12.2 Million - $21.3 Million
833,721 Added 33.61%
3,314,569 $54.5 Million
Q4 2017

Jan 18, 2018
BUY
$15.77 - $20.72 $2.92 Million - $3.84 Million
185,454 Added 8.08%
2,480,848 $44.8 Million
Q3 2017

Oct 13, 2017
BUY
$12.3 - $19.3 $28.2 Million - $44.3 Million
2,295,394
2,295,394 $44.3 Million

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email